 Connection
Sridharan Raghavan to Treatment Outcome
This is a "connection" page, showing publications Sridharan Raghavan has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.091 |
|
|
|
-
Raghavan S, Josey K, Bahn G, Reda D, Basu S, Berkowitz SA, Emanuele N, Reaven P, Ghosh D. Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control. Ann Epidemiol. 2022 01; 65:101-108.
Score: 0.059
-
Derington CG, Li H, Zhang Y, Lu CC, Jaeger BC, Cohen JB, Muntner P, Shimbo D, Cushman WC, Berlowitz DR, Raghavan S, Ho PM, Hausmann LRM, Bress AP, Mohanty AF. Blood Pressure Outcomes Among US Veterans Initiating Hypertension Treatment, 2014 to 2023. Circ Popul Health Outcomes. 2026 Aug; 19(8):e013272.
Score: 0.021
-
Basu S, Raghavan S, Wexler DJ, Berkowitz SA. Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial. Diabetes Care. 2018 03; 41(3):604-612.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|